Fusiwal B Cream is a topical medication combining Beclometasone dipropionate (0.025% w/w), a potent corticosteroid, with Fusidic Acid (2% w/w), a bacteriostatic antibiotic. This combination is specifically formulated to treat inflammatory skin conditions complicated by bacterial infections. Beclometasone works by reducing inflammation, redness, and itching through its anti-inflammatory and immunosuppressive properties, providing symptomatic relief in conditions such as eczema, dermatitis, and psoriasis. Fusidic Acid targets susceptible bacteria by inhibiting bacterial protein synthesis, effectively controlling secondary bacterial infections commonly associated with inflamed or damaged skin. Fusiwal B Cream is indicated for use in infected eczema, impetigo, infected dermatitis, and other superficial skin infections where inflammation and bacterial colonization coexist. The cream should be applied in a thin layer to the affected area, typically two to three times daily, as directed by a healthcare professional. It is important to avoid prolonged use to minimize potential side effects such as skin thinning or resistance development. Fusiwal B Cream is not recommended for use on large areas or broken skin without medical supervision. Patients should consult a healthcare provider before use, especially if pregnant, breastfeeding, or using other topical products.